May 15, 2018 / 7:31 PM / 10 days ago

BRIEF-Biophytis Receives Orphan Drug Designation In U.S. For Sarconeos In DMD

May 15 (Reuters) - Biophytis SA:

* BIOPHYTIS RECEIVES ORPHAN DRUG DESIGNATION IN THE UNITED STATES FOR SARCONEOS IN DUCHENNE MUSCULAR DYSTROPHY (DMD)

* BIOPHYTIS SA - HAS ALSO FILED AN APPLICATION FOR AN ORPHAN DRUG DESIGNATION FOR SARCONEOS IN DUCHENNE MYOPATHY WITH EMA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below